Endocrine News

January 2020

January 06, 2020

Here are some of the things you should be reading in this issue of Endocrine News.

2019: The Year in Review—Endocrine research remains at the forefront of medical breakthroughs — as we showed last month with our cover story “Eureka! The Year’s Biggest Discoveries in Endocrine Science” — which has led to cutting-edge treatment options, therapies, and products. Endocrine News reviews some of these new methods to treat a variety of endocrine complications as we kick off a new decade.

Trust But Verify: The Impact of Erroneous ACTH Assays—An ACTH assay’s accuracy became so concerning that it warranted a paper in the Journal of the Endocrine Society that detailed five separate cases. Raising awareness of this rare but serious issue can avoid misdiagnoses that put patients in peril.

The Eyes Have It: The Effects of Thyroid Eye Disease—Endocrine News gets the patient and physician perspective on thyroid eye disease. Patients discuss how it has affected their lives, and clinicians explain the limited treatment choices. However, new options may be on the horizon.

AFTERMATH: What Happens Next After Thyroid Cancer Treatment?—The challenges of managing thyroid cancer patients include regulating their hormone replacement therapy and monitoring for recurrence. Here, we highlight an upcoming ENDO 2020 session that details the issues in treating patients post-thyroid cancer therapy.

Vitamin D: When Enough Is Enough—Vitamin D enthusiasts have long promoted high doses to obtain hoped-for benefits, but clinical trials are not finding them.

And so much more.

Read Online or Download the Issue

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.